Gastric Cancer

The ACG has released its first guidance for gastric premalignant conditions, such as atrophic gastritis, gastric intestinal metaplasia and dysplasia, in sync with surveillance recommendations established for the colon and esophagus.

Genomic cancer predisposition tests should be done with professional counseling, and the FDA should implement safeguards for direct-to-consumer products, according to a medical oncologist with expertise in cancer genetics.

A new electronic health record-based model accurately predicted risk for gastric cancer using demographic, behavioral and clinical data and may be leveraged to increase screening in at-risk populations.

The FDA has approved nivolumab and hyaluronidase-nvhy for subcutaneous injection in adults with solid tumors in which nivolumab is indicated, according to a press release.

A no-drain strategy after gastrectomy increased the risk for reoperation or percutaneous drain placement within 30 days compared with prophylactic drainage among patients with gastric cancer, according to a study published in JAMA Surgery.

The addition of preoperative chemoradiotherapy to standard perioperative chemotherapy did not improve survival for certain patients with resectable gastric cancer, according to results of a randomized phase 3 trial.

Gastric Cancer Awareness Month, observed every November, is intended to educate the public about the potential causes and risk factors for the disease.

An invitation to screen for Helicobacter pylori along with fecal immunochemical testing did not significantly reduce gastric cancer incidence or mortality over approximately 5 years vs. FIT alone, according to a study conducted in Taiwan.

In 2021, Jessica Sheth Bhutada, MD, MS, and colleagues uncovered a startling 2% annual uptick in metastatic stomach cancer in young adults, despite declining rates in older adults. Three years later, they are still trying to understand why.